Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si Shi

Showing results (311-320 of 315) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 315 results.
Annals of Surgery|February 25, 2025
Effect of Laparoscopic versus Open Distal Pancreatectomy on Recurrence-Free Survival in Patients with Left-sided Pancreatic Cancer: A randomized controlled trialChen Liu, He Cheng, Min Wang, et al.
Science (New York, N.Y.)|May 2, 2024
A blueprint for tumor-infiltrating B cells across human cancersJiaqiang Ma, Yingcheng Wu, Lifeng Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2024
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trialPanpan Zhang, Si Shi, Jianming Xu, et al.
Cell|January 18, 2025
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patientsLiping Zhong, Lu Gan, Bing Wang, et al.
Nature Medicine|January 29, 2024
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinomaLingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Pageof 32

Showing results (311-320 of 315) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 315 results.
Annals of Surgery|February 25, 2025
Effect of Laparoscopic versus Open Distal Pancreatectomy on Recurrence-Free Survival in Patients with Left-sided Pancreatic Cancer: A randomized controlled trialChen Liu, He Cheng, Min Wang, et al.
Science (New York, N.Y.)|May 2, 2024
A blueprint for tumor-infiltrating B cells across human cancersJiaqiang Ma, Yingcheng Wu, Lifeng Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2024
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trialPanpan Zhang, Si Shi, Jianming Xu, et al.
Cell|January 18, 2025
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patientsLiping Zhong, Lu Gan, Bing Wang, et al.
Nature Medicine|January 29, 2024
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinomaLingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Pageof 32